The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
Open accessAbstract
The development of highly active antiretroviral therapy (HAART) to treat individuals infected with HIV-1 has dramatically improved patient outcomes, but HAART still fails to cure the infection. The latent viral reservoir in resting CD4+ T cells is a major barrier to virus eradication. Elimination of this reservoir requires reactivation of the latent virus. However, strategies for reactivating HIV-1 through nonspecific T cell activation have clinically unacceptable toxicities. We describe here the development of what we believe to be a novel in vitro model of HIV-1 latency that we used to search for compounds that can reverse latency. Human primary CD4+ T cells were transduced with the prosurvival molecule Bcl-2, and the resulting cells were shown to recapitulate the quiescent state of resting CD4+ T cells in vivo. Using this model system, we screened small-molecule libraries and identified a compound that reactivated latent HIV-1 without inducing global T cell activation, 5-hydroxynaphthalene-1,4-dione (5HN). Unlike previously described latency-reversing agents, 5HN activated latent HIV-1 through ROS and NF-kappaB without affecting nuclear factor of activated T cells (NFAT) and PKC, demonstrating that TCR pathways can be dissected and utilized to purge latent virus. Our study expands the number of classes of latency-reversing therapeutics and demonstrates the utility of this in vitro model for finding strategies to eradicate HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Self-citationCentral Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Self-citationAn inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Self-citationNFAT proteins: key regulators of T-cell development and function
Macian, F. (2005) · Nature Reviews Immunology · doi:10.1038/nri1632 · Cited by 1,569
NF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,537
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
Jordan, A., Bisgrove, D., & Verdin, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg188 · Cited by 914
Cytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell Line
Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A., & Fauci, A. S. (1987) · Science · doi:10.1126/science.3313729 · Cited by 905
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Chun, T.-W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787
Self-citationDuh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., & Rabson, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5974 · Cited by 767
Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 712
The Challenge of Viral Reservoirs in HIV-1 Infection
Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 627
Self-citationIntracellular production of superoxide radical and of hydrogen peroxide by redox active compounds
Hassan, H. M., & Fridovich, I. (1979) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(79)90289-3 · Cited by 596
Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice
Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R., & Weissman, I. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80291-3 · Cited by 593
Pierson, T., McArthur, J., & Siliciano, R. F. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.665 · Cited by 545
Self-citationDepletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Maraskovsky, E., O'Reilly, L. A., Teepe, M., Corcoran, L. M., Peschon, J. J., & Strasser, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80289-5 · Cited by 493
Interleukin 7 Regulates the Survival and Generation of Memory CD4 Cells
Kondrack, R. M., Harbertson, J., Tan, J. T., McBreen, M. E., Surh, C. D., & Bradley, L. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030735 · Cited by 471
IL-7 Enhances the Survival and Maintains the Size of Naive T Cells
Rathmell, J. C., Farkash, E. A., Gao, W., & Thompson, C. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6869 · Cited by 459
Chun, T.-W., Engel, D., Mizell, S. B., Hallahan, C. W., Fischette, M., Park, S., Davey, R. T., Dybul, M., Kovacs, J. A., Metcalf, J. A., et al. (1999) · Nature Medicine · doi:10.1038/9498 · Cited by 404
Böhnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R., & Greene, W. C. (1988) · Cell · doi:10.1016/0092-8674(88)90099-2 · Cited by 400
Protein Kinase Cθ in T Cell Activation
Isakov, N., & Altman, A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064807 · Cited by 376
Marrack, P., & Kappler, J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104554 · Cited by 362
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines
Chun, T.-W., Engel, D., Mizell, S. B., Ehler, L. A., & Fauci, A. S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.83 · Cited by 359
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Bosque, A., & Planelles, V. (2009) · Blood · doi:10.1182/blood-2008-07-168393 · Cited by 340
Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., & Pomerantz, R. J. (2001) · Blood · doi:10.1182/blood.v98.10.3006 · Cited by 329
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Shen, L., Peterson, S., Sedaghat, A. R., McMahon, M. A., Callender, M., Zhang, H., Zhou, Y., Pitt, E., Anderson, K. S., Acosta, E. P., et al. (2008) · Nature Medicine · doi:10.1038/nm1777 · Cited by 327
Self-citationKinoshita, S., Su, L., Amano, M., Timmerman, L. A., Kaneshima, H., & Nolan, G. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80326-x · Cited by 318
Selective Inactivation of Parvulin-Like Peptidyl-Prolyl cis/trans Isomerases by Juglone
Hennig, L., Christner, C., Kipping, M., Schelbert, B., Rücknagel, K. P., Grabley, S., Küllertz, G., & Fischer, G. (1998) · Biochemistry · doi:10.1021/bi973162p · Cited by 315
IL-7 Promotes the Transition of CD4 Effectors to Persistent Memory Cells
Li, J., Huston, G., & Swain, S. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030725 · Cited by 309
Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O., & Reiser, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8873-8883.1998 · Cited by 308
A clinical drug library screen identifies astemizole as an antimalarial agent
Chong, C. R., Chen, X., Shi, L., Liu, J. O., & Sullivan, D. J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio806 · Cited by 289
Self-citationEmmendörffer, A., Hecht, M., Lohmann-Matthes, M.-L., & Roesler, J. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90198-5 · Cited by 282
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.
Tong-Starksen, S. E., Luciw, P. A., & Peterlin, B. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6845 · Cited by 271
Shapiro, H. M. (1981) · Cytometry · doi:10.1002/cyto.990020302 · Cited by 255
Wang, F.-X., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M., Najera, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522574 · Cited by 252
Prins, J. M., Jurriaans, S., van Praag, R. M. E., Blaak, H., van Rij, R., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S.-L., Fox, C. H., Roos, M. T. L., et al. (1999) · AIDS · doi:10.1097/00002030-199912030-00012 · Cited by 237
The multifactorial nature of HIV-1 latency
Lassen, K., Han, Y., Zhou, Y., Siliciano, J., & Siliciano, R. F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.006 · Cited by 235
Self-citationHMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
Contreras, X., Barboric, M., Lenasi, T., & Peterlin, B. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030146 · Cited by 206
Molecular Characterization, Reactivation, and Depletion of Latent HIV
Brooks, D. G., Hamer, D. H., Arlen, P. A., Gao, L., Bristol, G., Kitchen, C. M. R., Berger, E. A., & Zack, J. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00236-x · Cited by 192
Scripture-Adams, D. D., Brooks, D. G., Korin, Y. D., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13077-13082.2002 · Cited by 183
Swiggard, W. J., Baytop, C., Yu, J. J., Dai, J., Li, C., Schretzenmair, R., Theodosopoulos, T., & O'Doherty, U. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14179-14188.2005 · Cited by 182
Zhang, H., Zhou, Y., Alcock, C., Kiefer, T., Monie, D., Siliciano, J., Li, Q., Pham, P., Cofrancesco, J., Persaud, D., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1718-1729.2004 · Cited by 180
Self-citationGeneration of HIV latency during thymopoiesis
Brooks, D. G., Kitchen, S. G., Kitchen, C. M. R., Scripture-Adams, D. D., & Zack, J. A. (2001) · Nature Medicine · doi:10.1038/86531 · Cited by 177
Lassen, K. G., Bailey, J. R., & Siliciano, R. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9105-9114.2004 · Cited by 164
Self-citationPierson, T. C., Hoffman, T. L., Blankson, J. N., Finzi, D., Chadwick, K. R., Margolick, J. B., Buck, C. B., Siliciano, J. D., Doms, R. W., & Siliciano, R. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7824-7833.2000 · Cited by 163
Self-citationNonproductive Human Immunodeficiency Virus Type 1 Infection in Nucleoside-Treated G 0 Lymphocytes
Korin, Y. D., & Zack, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6526-6532.1999 · Cited by 149
Sakai, K., Dimas, J., & Lenardo, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509417103 · Cited by 145
van Praag, R. M. E., Prins, J. M., Roos, M. T. L., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S. L., Schuitemaker, H., Eerenberg, A. J. M., Jurriaans, S., de Wolf, F., et al. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011091300321 · Cited by 140
Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection
Geeraert, L., Kraus, G., & Pomerantz, R. J. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.062806.123001 · Cited by 138
Dai, J., Agosto, L. M., Baytop, C., Yu, J. J., Pace, M. J., Liszewski, M. K., & O’Doherty, U. (2009) · Journal of Virology · doi:10.1128/jvi.01910-08 · Cited by 122
Identification of T cell-signaling pathways that stimulate latent HIV in primary cells
Brooks, D. G., Arlen, P. A., Gao, L., Ramirez, C. M., & Zack, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233345100 · Cited by 117
Chen, B. K., Feinberg, M. B., & Baltimore, D. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5495-5504.1997 · Cited by 106
An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency
Marini, A., Harper, J. M., & Romerio, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7713 · Cited by 103
Kittipatarin, C., & Khaled, A. R. (2007) · Cytokine · doi:10.1016/j.cyto.2007.07.183 · Cited by 99
Superoxide, hydrogen peroxide, and oxygen toxicity in two free-living nematode species
Blum, J., & Fridovich, I. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90499-x · Cited by 87
Sahu, G. K., Lee, K., Ji, J., Braciale, V. L., Baron, S., & Cloyd, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.07.020 · Cited by 77
Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells
Choudhary, S. K., Archin, N. M., & Margolis, D. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/529525 · Cited by 73
Death and Baxes: mechanisms of lymphotrophic cytokines
Khaled, A. R., & Durum, S. K. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00050.x · Cited by 69
Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4 + T Cells
Vatakis, D. N., Kim, S., Kim, N., Chow, S. A., & Zack, J. A. (2009) · Journal of Virology · doi:10.1128/jvi.00356-09 · Cited by 64
HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture
Sylwester, A. W., Murphy, S., Shutt, D. C., & Soll, D. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3996 · Cited by 64
Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis
Fila, C., Metz, C. H. G., & van der Sluijs, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710264200 · Cited by 62
Ledford, H. K. (2007) · Nature · doi:10.1038/450325a · Cited by 42
Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus
Burke, B. P., Brown, H. J., Marsden, M. D., Bristol, G. C., Vatakis, D. N., & Zack, J. A. (2007) · Journal of Virology · doi:10.1128/jvi.02838-06 · Cited by 37
NF-κB and HIV: Linking viral and immune activation
Rabson, A. B., & Lin, H.-C. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)48006-3 · Cited by 32
Cited by
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Self-citationHIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
Self-citationComparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Eriksson, S., Graf, E. H., Dahl, V., Strain, M. C., Yukl, S. A., Lysenko, E. S., Bosch, R. J., Lai, J., Chioma, S., Emad, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003174 · Cited by 567
Self-citationTowards an HIV cure: a global scientific strategy
The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature Reviews Immunology · doi:10.1038/nri3262 · Cited by 554
Metadata
- Authors
- Yang, H.-C., Xing, S., Shan, L., O’Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., Zhang, H., Margolick, J. B., & Siliciano, R. F.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-10-01
- Volume
- 119
- Issue
- 11
- Pages
- 3473-86
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2150668958
- Cited by
- 258
- References
- 73
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.